Status:
COMPLETED
Clinical Outcomes From NOCD Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention
Lead Sponsor:
NOCD
Conditions:
Obsessive-Compulsive Disorder
Eligibility:
All Genders
10+ years
Brief Summary
This is a naturalistic, observational study of individuals with obsessive-compulsive disorder who were treated with exposure and response prevention via video teletherapy, augmented with between-sessi...
Eligibility Criteria
Inclusion
- obsessive-compulsive disorder
Exclusion
- none
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 8 2020
Estimated Enrollment :
2069 Patients enrolled
Trial Details
Trial ID
NCT04701372
Start Date
January 1 2020
End Date
November 8 2020
Last Update
January 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nocd, Llc
Chicago, Illinois, United States, 60601